BACKGROUND: Health-related quality of life (HRQOL) questionnaires should ideally be adapted to the individual patient and at the same time scores should be directly comparable across patients. This is achievable using a computerised adaptive test (CAT). Basing the CAT on an existing instrument enables measurement within an established HRQOL framework and allows backward-compatibility with studies using the original instrument. Because of these advantages the EORTC Quality of Life Group (QLG) has initiated a project to develop a CAT version of the widely used EORTC QLQ-C30. METHODS: We present the EORTC QLG's strategy for developing a CAT. For each dimension of the EORTC QLQ-C30 our approach includes literature search and conceptualisation, formulation of new items, expert and patient evaluations, field-testing, and psychometric analyses of the items. The strategy is illustrated with the initial results of the development of CAT for physical functioning (PF). RESULTS: We identified 975 PF items in the literature. Of these, 407 items were deemed relevant, i.e. measured one of the PF aspects measured by the QLQ-C30. Based on these items we developed 86 new items. Review by the EORTC CAT-project group reduced this to 66 items. Based on expert and patient evaluations several items were revised and the list was further reduced to 51 items. CONCLUSIONS: Based on the findings for PF, we believe that our approach will generate item pools that are relevant and appropriate for cancer patients. These will form the basis for a backward-compatible CAT assessing the HRQOL dimensions of the EORTC QLQ-C30. Copyright (c) 2010 Elsevier Ltd. All rights reserved.
BACKGROUND: Health-related quality of life (HRQOL) questionnaires should ideally be adapted to the individual patient and at the same time scores should be directly comparable across patients. This is achievable using a computerised adaptive test (CAT). Basing the CAT on an existing instrument enables measurement within an established HRQOL framework and allows backward-compatibility with studies using the original instrument. Because of these advantages the EORTC Quality of Life Group (QLG) has initiated a project to develop a CAT version of the widely used EORTC QLQ-C30. METHODS: We present the EORTC QLG's strategy for developing a CAT. For each dimension of the EORTC QLQ-C30 our approach includes literature search and conceptualisation, formulation of new items, expert and patient evaluations, field-testing, and psychometric analyses of the items. The strategy is illustrated with the initial results of the development of CAT for physical functioning (PF). RESULTS: We identified 975 PF items in the literature. Of these, 407 items were deemed relevant, i.e. measured one of the PF aspects measured by the QLQ-C30. Based on these items we developed 86 new items. Review by the EORTC CAT-project group reduced this to 66 items. Based on expert and patient evaluations several items were revised and the list was further reduced to 51 items. CONCLUSIONS: Based on the findings for PF, we believe that our approach will generate item pools that are relevant and appropriate for cancerpatients. These will form the basis for a backward-compatible CAT assessing the HRQOL dimensions of the EORTC QLQ-C30. Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Authors: Lise Holst Thamsborg; Morten Aa Petersen; Neil K Aaronson; Wei-Chu Chie; Anna Costantini; Bernhard Holzner; Irma M Verdonck-de Leeuw; Teresa Young; Mogens Groenvold Journal: Support Care Cancer Date: 2014-11-14 Impact factor: 3.603
Authors: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young Journal: Qual Life Res Date: 2010-10-23 Impact factor: 4.147
Authors: Stephen T Tiffany; Lawrence Friedman; Shelly F Greenfield; Deborah S Hasin; Ron Jackson Journal: Addiction Date: 2011-10-07 Impact factor: 6.526
Authors: Mirelle Lagendijk; Elizabeth Mittendorf; Tari A King; Christopher Gibbons; Andrea Pusic; Laura S Dominici Journal: Oncologist Date: 2019-12-17
Authors: Therese Juul; Morten Aagaard Petersen; Bernhard Holzner; Søren Laurberg; Peter Christensen; Mogens Grønvold Journal: Qual Life Res Date: 2014-03-28 Impact factor: 4.147
Authors: Morten Aa Petersen; Johannes M Giesinger; Bernhard Holzner; Juan I Arraras; Thierry Conroy; Eva-Maria Gamper; Madeleine T King; Irma M Verdonck-de Leeuw; Teresa Young; Mogens Groenvold Journal: Qual Life Res Date: 2013-02-28 Impact factor: 4.147
Authors: Freya Trautmann; Leopold Hentschel; Beate Hornemann; Anke Rentsch; Michael Baumann; Gerhard Ehninger; Jochen Schmitt; Markus Schuler Journal: Support Care Cancer Date: 2016-02-18 Impact factor: 3.603
Authors: Bernhard Holzner; Johannes M Giesinger; Jakob Pinggera; Stefan Zugal; Felix Schöpf; Anne S Oberguggenberger; Eva M Gamper; August Zabernigg; Barbara Weber; Gerhard Rumpold Journal: BMC Med Inform Decis Mak Date: 2012-11-09 Impact factor: 2.796
Authors: Linda Dirven; Martin Jb Taphoorn; Mogens Groenvold; Esther Jj Habets; Neil K Aaronson; Thierry Conroy; Jaap C Reijneveld; Teresa Young; Morten Aa Petersen Journal: Neurooncol Pract Date: 2017-01-19
Authors: Morten Aa Petersen; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Eva Hammerlid; Marianne J Hjermstad; Stein Kaasa; Jon H Loge; Galina Velikova; Teresa Young; Mogens Groenvold Journal: Qual Life Res Date: 2015-08-13 Impact factor: 4.147